JASPER THERAPEUTICS, INC. Conversion of Stock, Shares Issued
JASPER THERAPEUTICS, INC. (JSPR) reported Conversion of Stock, Shares Issued of 2.34 million shares for the 1-month period ending 2023-01-31, per its 10-Q filed 2023-05-12.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:ConversionOfStockSharesIssued1 · last filed 2023-08-11
- 2023-01-31: Conversion of Stock, Shares Issued 2.34M shares; Conversion of Stock, Shares Issued 1 month 2.34M shares.
| Period end | Conversion of Stock, Shares Issued | Conversion of Stock, Shares Issued 1 month |
|---|---|---|
| 2023-01-31 | 2.34M shares 10-Q · filed 2023-08-11 | 2.34M shares 10-Q · filed 2023-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |